Primary Job Title Chairman Primary Organization 
Lysosomal Therapeutics
Gender Male
LinkedIn View on LinkedIn
Bob Carpenter is a successful entrepreneur, having founded and lead several companies, such as VacTex Inc. (acquired by Aquila Biopharmaceuticals in 1998), and GelTex Pharmaceuticals and Integrated Genetics, both merged with Genzyme.
Following the merger of IG, Bob was EVP, CEO and chairman of Genzyme’s subsidiary IG Laboratories till 1991, and
served as a Director on Genzyme’s Board until its acquisition. He’s currently Chairman of Hydra Biosciences.
